000 01411 a2200385 4500
005 20250518071311.0
264 0 _c20200706
008 202007s 0 0 eng d
022 _a1460-2156
024 7 _a10.1093/brain/awz328
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSilva, Ana C
245 0 0 _aAntisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders.
_h[electronic resource]
260 _bBrain : a journal of neurology
_c02 2020
300 _a407-429 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aHumans
650 0 4 _aHuntingtin Protein
_xdrug effects
650 0 4 _aHuntington Disease
_xdrug therapy
650 0 4 _aNeurodegenerative Diseases
_xdrug therapy
650 0 4 _aOligonucleotides, Antisense
_xpharmacology
650 0 4 _aPeptides
_xgenetics
650 0 4 _aTrinucleotide Repeat Expansion
_xgenetics
700 1 _aLobo, Diana D
700 1 _aMartins, Inês M
700 1 _aLopes, Sara M
700 1 _aHenriques, Carina
700 1 _aDuarte, Sónia P
700 1 _aDodart, Jean-Cosme
700 1 _aNobre, Rui Jorge
700 1 _aPereira de Almeida, Luis
773 0 _tBrain : a journal of neurology
_gvol. 143
_gno. 2
_gp. 407-429
856 4 0 _uhttps://doi.org/10.1093/brain/awz328
_zAvailable from publisher's website
999 _c30323971
_d30323971